Salix Pharmaceuticals Ltd (SLXP)

172.81
0.16 0.09
NASDAQ : Health Care
Prev Close 172.65
Open 172.72
Day Low/High 172.71 / 172.96
52 Wk Low/High 86.00 / 172.98
Volume 4.30M
Avg Volume 3.38M
Exchange NASDAQ
Shares Outstanding 64.25M
Market Cap 11.10B
EPS -6.53
P/E Ratio N/A
Div & Yield N.A. (N.A)

Stick With the Price Action

It's the only way to deal with this market.

Market News: Sears, Salix Pharmaceuticals, Walt Disney

Market News: Sears, Salix Pharmaceuticals, Walt Disney

The Department of Labor reported that American companies added 214,000 jobs and the unemployment rate declined to 5.8%The stock markets in the United States fluctuated and eventually ended the trading...

Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data

Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data

The Dow Jones Industrial Average posts a small gain in the final minutes to closing bell, just enough to cement the index's third consecutive record close.

SHAREHOLDER ALERT: Investigation On Behalf Of Salix Pharmaceuticals, Ltd. Investors Announced By Law Offices Of Howard G. Smith

SHAREHOLDER ALERT: Investigation On Behalf Of Salix Pharmaceuticals, Ltd. Investors Announced By Law Offices Of Howard G. Smith

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Salix Pharmaceuticals, Ltd.

Stock Market Today: Dow, S&P 500 Give Up Small Gains in Final Hour

Stock Market Today: Dow, S&P 500 Give Up Small Gains in Final Hour

U.S. stocks slip on Friday afternoon, though with only slight moves, as Wall Street overlooks a mixed October jobs report to digest the big picture of a tightening labor market.

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against Salix Pharmaceuticals Ltd. - SLXP

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against Salix Pharmaceuticals Ltd. - SLXP

The Rosen Law Firm announces that it is investigating potential securities claims against Salix Pharmaceuticals Ltd.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AAWW, BSF, CRZO, GCAP, HSTM, INWK, KLIC, KRNY, MOH, MSCC, QUAD, RT, SEMG, SMMF, SUN, USCR Downgrades: AKRX, ALSK, ARPI, CTP, CVI, DAR, EPM, OAS, PEOP, QLTY, SLXP, TNH, TREE, UGP, WIN Initiations: FMI Read on to get TheStreet Quant Ratings' detailed report:

Cramer: Salix Pharmaceuticals' Audit Committee Review Is Concerning

Cramer: Salix Pharmaceuticals' Audit Committee Review Is Concerning

TheStreet's Jim Cramer takes a look at Salix Pharmaceuticals, whose stock is plunging after the company announced a slew of bad news.

Today's Pre-Market Mover With Heavy Volume: Salix Pharmaceuticals (SLXP)

Today's Pre-Market Mover With Heavy Volume: Salix Pharmaceuticals (SLXP)

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a pre-market mover with heavy volume candidate

Salix Shares Plummet on Disclosure of Accounting Scandal

Salix Shares Plummet on Disclosure of Accounting Scandal

Salix Pharmaceuticals has been rocked by an accounting scandal involving inventory levels of its key gastrointestinal drugs, forcing the company to cut financial forecasts for the rest of the year.

Salix Pharmaceuticals (SLXP) Falling In After-Hours Activity

Salix Pharmaceuticals (SLXP) Falling In After-Hours Activity

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a post-market laggard candidate

Salix Pharmaceuticals Reports 3Q2014 Results

Salix Pharmaceuticals Reports 3Q2014 Results

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced financial and operating results for the third quarter ended September 30, 2014, and provided other business updates.

Salix Pharmaceuticals Appoints Acting Chief Financial Officer

Salix Pharmaceuticals Appoints Acting Chief Financial Officer

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced the appointment of Timothy J.

Salix And Pharming Announce The Launch Of RUCONEST® In The U.S. For The Treatment Of Acute Angioedema Attacks In Patients With Hereditary Angioedema (HAE)

Salix And Pharming Announce The Launch Of RUCONEST® In The U.S. For The Treatment Of Acute Angioedema Attacks In Patients With Hereditary Angioedema (HAE)

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Pharming Group NV (EURONEXT: PHARM) today announced the launch of RUCONEST ® (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg in the United States for the treatment...

Volatile Market Presents Mixed Bag

I see bargains, but would avoid some of the big-name momentum stocks.

Salix Pharmaceuticals Announces 3Q2014 Financial Results Conference Call And Webcast

Salix Pharmaceuticals Announces 3Q2014 Financial Results Conference Call And Webcast

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report third quarter 2014 financial results following the close of the U.

Salix Pharmaceuticals Outlines Data Presentations At American College Of Gastroenterology 2014 Annual Scientific Meeting

Salix Pharmaceuticals Outlines Data Presentations At American College Of Gastroenterology 2014 Annual Scientific Meeting

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that presentations related to research of two of the Company’s products are scheduled to take place during the American College of Gastroenterology (ACG)...

Mid-cap stocks and the Goldilocks economy

Mid-cap stocks and the Goldilocks economy

Mid-cap stocks had better immunity to recent market volatility than smaller companies.

FDA Approves UCERIS® (Budesonide) 2mg Rectal Foam For The Induction Of Remission Of Mild-to-Moderate Distal Ulcerative Colitis

FDA Approves UCERIS® (Budesonide) 2mg Rectal Foam For The Induction Of Remission Of Mild-to-Moderate Distal Ulcerative Colitis

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Food and Drug Administration (FDA) has granted final approval for UCERIS® (budesonide) rectal foam for the induction of remission in patients with ...

Stock Market Today: Stocks Log Weekly Loss Despite Friday's Surge

Stock Market Today: Stocks Log Weekly Loss Despite Friday's Surge

U.S. markets end the week in the red, despite a jobs-data-inspired rally on Friday.

Stock Market Today: Friday Rally Fails to Recover Week's Losses

Stock Market Today: Friday Rally Fails to Recover Week's Losses

U.S. stocks are rallying on Friday on positive jobs sentiment, but not enough to recover from the week's losses.

Why Salix Pharmaceuticals (SLXP) Stock Is Gaining Today

Why Salix Pharmaceuticals (SLXP) Stock Is Gaining Today

Salix Pharmaceuticals (SLXP) shares are climbing after the company announced that it had changed its mind about purchasing Dublin based Cosmo Technologies.

Salix Seen as Target After Scrapping Tax Inversion Cosmo Purchase

Salix Seen as Target After Scrapping Tax Inversion Cosmo Purchase

North Carolina drugmaker cites the "changed political environment" for its decision to back out of a tax inversion deal to buy the Italian company.

Stock Market Today: Stocks Surge, Gold Dips, as Hiring Picks Up

Stock Market Today: Stocks Surge, Gold Dips, as Hiring Picks Up

U.S. stocks are snapping back after a stronger-than-expected jobs report that saw the jobless rate dip to its lowest since July 2008.

Pre-Market Activity Shows Heavy Volume And Movement For Salix Pharmaceuticals (SLXP)

Pre-Market Activity Shows Heavy Volume And Movement For Salix Pharmaceuticals (SLXP)

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a pre-market mover with heavy volume candidate

Stock Market Today: Futures Jump as Jobs Rebound in September

Stock Market Today: Futures Jump as Jobs Rebound in September

U.S. stock index futures are gaining ground Friday after a robust U.S. nonfarm payrolls report and firm trade data.

Why Salix Pharmaceuticals (SLXP) Stock Is Surging Today

Why Salix Pharmaceuticals (SLXP) Stock Is Surging Today

The company is reportedly in talks to sell itself to Actavis (ACT) after it failed to reach a deal with Allergan (AGN).

October 3 Premarket Briefing: 10 Things You Should Know

October 3 Premarket Briefing: 10 Things You Should Know

U.S. stock futures rise ahead of U.S. jobs report; JPMorgan data breach affects 76 million households; Salix terminates merger with Cosmo; Facebook gets EU go-ahead for WhatsApp merger.